TERRE HAUTE — While politicians and the news media focus on the fate of President Obama’s version of health care reform, a fascinating (and oh-so-revealing) historical element of the proposal begs for attention:
A veiled and very expensive negotiation process led to some extraordinary agreements between the White House and the pharmaceutical industry that were included in the final congressional versions of the overhaul.
The saga of how those agreements were reached is expertly laid out online by investigative reporter Paul Blumenthal of the Sunlight Foundation (sunlightfoundation.com). It ought to be mandatory reading for every American over the age of 16 who wants to know how national politics really gets done, no matter which party is in charge.
Blumenthal’s account of the cozy affair between the Obama administration and Big Pharma already has caught the attention of government transparency geeks – and it should force the left and right fringes to abandon any notions that Obama is an enemy of capitalism.
On Monday, as the president released his $950 billion health care reform proposal, Blumenthal recapped behind-the-scenes details of the affair for “Fresh Air” host Terry Gross on National Public Radio.
Blumenthal’s report begins with the 2009 inauguration of Barack Obama, who had promised as a candidate to reform the prescription drug industry and wrest Washington from the grubby mitts of multibillion-dollar lobbyists.
But as White House and congressional documents and a plethora of published reports by other journalists revealed to Blumenthal: “Over the following months, pharmaceutical industry lobbyists and executives met with top White House aides dozens of times to hammer out a deal that would secure industry support for the administration’s health care reform agenda in exchange for the White House abandoning key elements of the president’s promises to reform the pharmaceutical industry. They flooded Congress with campaign contributions, and hired dozens of former Capitol Hill insiders to push their case.”
“They” were led by Billy Tauzin, CEO of the nation’s most powerful lobbying organization for the drug industry, the Pharmaceutical Research and Manufacturers of America, or PhRMA.
Tauzin of Louisiana is a 25-year veteran of Congress and a one-man monument to the insignificance of party affiliation for success in Washington, D.C. He spent 15 years as a conservative House Democrat, then hopped over the aisle in mid-1995 to become a Republican.
He remained there until January 2005, using his position as chairman of the House Energy and Commerce Committee to shepherd the Medicare prescription drug bill to completion – and to the delight of the pharmaceutical industry.
With that bill, Americans not only got stuck with a substantial “donut hole” in drug benefits coverage, but they also lost the opportunity for Medicare to negotiate lower drug prices with the industry, for consumers to buy cheaper medicines from non-U.S. manufacturers, and for a shorter wait for expensive, brand-name drugs to become affordable generics.
Tauzin’s very next job? Head lobbyist for the grateful pharmaceutical industry, with a reported salary of $2 million a year.
According to Blumenthal’s research, Tauzin was a frequent but quiet visitor last year to the White House and to the office of its declared go-to health care guy in Congress, Sen. Max Baucus. So, too, were a small army of drug industry executives and other lobbyists.
“Over the course of 2009, the drug industry trade group spent over $28 million on in-house and hired lobbyists,” Blumenthal wrote. “Aside from PhRMA’s massive in-house lobbying operation, the trade group hired 48 outside lobbying firms. The total number of lobbyists working for PhRMA in 2009 reached 165.”
The truly stunning capper: “Some 137 of those 165 lobbyists representing PhRMA were former employees of either the legislative or executive branches.”
Not surprising, as Blumenthal reported, “Drug makers contributed huge sums to congressional campaign committees during the same period – from January to the end of October (fourth-quarter numbers are still being totaled), industry political action committees, employees and their family members flooded lawmakers with over $8 million.”
Really not surprising, “Those contributions tilted heavily to Democrats over Republicans by a 57 to 42 percent margin — the first time in any election cycle going back to 1990 …”
Blumenthal reproduces the many guest lists for the White House talks or those with Baucus or his staff. He provides context for the uncharacteristic public enthusiasm displayed by PhRMA for the administration’s drive for health care reform; Tauzin called it a once-in-a-lifetime opportunity for his industry and government to “make this hope for a better tomorrow a reality today.”
As Blumenthal observed: “This ‘once-in-a-lifetime’ opportunity also extended to the pharmaceutical industry’s ability to blunt the long-term Democratic agenda of lowering prescription drug prices through Medicare negotiations, re-importation [of foreign-made drugs] and quicker release of generics onto the market.”
Those agenda sacrifices are exactly what the drug industry received for alleged cost-cutting concessions of $80 billion.
One of the most distasteful elements of the insider maneuverings, however, falls directly on the Obama administration. After a meeting with White House and Baucus staff members, representatives of PhRMA, other health care groups and labor created a pair of pro-reform nonprofits that were bankrolled primarily by PhRMA.
Blumenthal reported: “The two groups spent $24 million on their advertising campaigns; the contract to produce and place ads went to White House Senior Advisor David Axelrod’s former firm, AKPD, which owed Axelrod $2 million.”
The irony, of course, is all that pharmaceutical industry money – more than $100 million on TV advertising, alone – bought little. Sweeping health care reform is, effectively, dead. The White House has crafted a hybrid version of the Senate and House bills and tossed it out to what most experts predict will be a futile, bipartisan health care summit Thursday.
Missing in Obama’s plan are some key previous agreements – the drug industry’s reprieve from being forced to shrink the donut hole and from Federal Trade Commission involvement in the slow, murky process of converting name-brand drugs into generics.
It would be fun to contemplate the karmic backfire from this unholy alliance of White House and Big Pharma if not for one overriding reality. The biggest losers in this story are not the makers of pharmaceuticals or the Obama administration; they are, once again, the U.S. health care consumer and a democracy free of the poison of Washington lobbyists.
Stephanie Salter can be reached at (812) 231-4229 or stephanie.salter@tribstar.com.
Stephanie Salter
STEPHANIE SALTER: An image to make one wonder: The Rx drug industry and White House in bed
- Stephanie Salter
-
-
STEPHANIE SALTER: The more things change, the more they … change
What the late, great Pittsburgh Pirates slugger knew, so knew the ancient philosopher, Heraclitus, the Buddha and Andy Warhol.
-
STEPHANIE SALTER: Making room for the least among us — and their kin
Christmas. Quiet time. Down time. Not exactly the kind of day most folks tend to contemplate their fellow Americans behind bars. And yet, the United States leads the world in percentage of population in jail or prison, far ahead of second-place Russia. About 2.3 million people — nearly one in 100 adults — are incarcerated in this country.
-
STEPHANIE SALTER: Carols for the worn, weary and wigged out
For those who are agog and aglow with “the season” — you who start bouncing and humming in Toys R Us at the intro guitar notes of “Jingle Bell Rock” — better search elsewhere for a soul mate.
-
STEPHANIE SALTER: Times change. Things disappear. Toilet paper here to stay
You may have seen an email going around with “Nine Things That Will Disappear in Our Lifetime.”
-
STEPHANIE SALTER: What I learned on election day
When I identified myself as a volunteer for the non-incumbent mayoral candidate, the woman on the other end of the line cut me off. “Save your breath, dear,” she said.
-
STEPHANIE SALTER: Of politics, protests, coupons and e-wishes
It’s roundup time again, that periodic hunting down and herding together of items that have but one thing in common: They grabbed me.
-
STEPHANIE SALTER: ‘Understandable’ not the same as ‘wise’
Because I’m not running for office and don’t plan to, I figure I am free to publicly question the designation of some 30 stretches of city streets as “memorial ways” for police and firefighters killed on the job.
-
STEPHANIE SALTER: Where have all the protest songs gone?
A telling moment came during the annual Eugene V. Debs award banquet late last month, when the career protest singer and songwriter, Anne Feeney, implored a huge Hulman Center audience to join her for the refrain of “We Shall Not Be Moved.”
-
STEPHANIE SALTER: It’s business as usual, but what does it cost to stay angry?
As painful and profoundly sad as the 10th anniversary of 9/11 has been, I found the actual day a balm.
-
STEPHANIE SALTER: The unfortunate bottom line … St. Ann’s will close
Ever since word came down that St. Ann Church and Parish have less than a year to live, there’s been much invoking of Elisabeth Kubler-Ross’ five stages of grief.
-
STEPHANIE SALTER: The Economy: One complex, thorny, bedeviling issue
No matter how much time and energy I spend trying to understand the Hydra we blithely call “The Economy,” I often worry that its mystery will forever elude me.
-
STEPHANIE SALTER: Thinking, now and then, about now and then
I am lying, poolside, in a plastic chaise lounge, listening to pop music and watching water droplets dry on my skin.
-
STEPHANIE SALTER: Thousands of things she would have missed
For several years, until she received an official information packet in the mail, my mother planned to donate her body to medical research.
-
STEPHANIE SALTER: Marriage? There’s an app for that ... but it’s tricky
As I watched all the happy people celebrating passage of New York’s same-sex marriage law, I couldn’t help but project to a time when Indiana adopts a similar statute.
-
STEPHANIE SALTER: Back in the saddle — with the usual burr under it
I really didn’t expect to be gone nearly six months, but then, that’s par for the course these days: What I expect to happen and what actually occurs are often about 180 degrees apart.
-
STEPHANIE SALTER: On the other hand … we’ll have a lot fewer leaves to rake
Editor’s Note: Former Tribune-Star Assistant Editor Stephanie Salter’s column resumes today in freelance form and will appear on this page every other Sunday.
TERRE HAUTE — My neighbor, Andy, had just lowered the bamboo blinds on his front porch when we heard a mournful sound. -
Memorable victories
This was about as much fun as a doubleheader split could get for Rose-Hulman’s baseball team.
-
STEPHANIE SALTER: Another batch of my status-quo-defending misinformation on schools
The day after state schools chief Tony Bennett responded to my three-column education series, a longtime friend and veteran teacher called.
“I just read the superintendent’s rebuttal in the Tribune-Star,” my friend said. “All I can conclude from it is that you are a dumbass. Welcome to the club. Anybody who doesn’t buy into his vision of education reform is considered a dumbass.” -
Stephanie Salter: One person’s roundup of significant folks lost in 2010
Every late December, as I comb through lists of notable deaths, I swear I will never repeat the process. It takes days of Internet research, mostly because I get distracted by looking up people about whom I know nothing.
-
Stephanie Salter: I've got some really good news for some of you guys
Of all the sentences I’ve imagined writing in my long, moss-covered newspaper career, this is not one of them: I am quitting my job to get married.
-
Stephanie Salter: A little history of mandated intermingling among U.S. troops
Back in July 1948, when President Harry Truman signed Executive Order 9981, predictions for its effect on the U.S. military were dire. Sen. Richard Brevard Russell Jr. of Georgia echoed the sentiments of millions of Americans in an address from the Senate floor.
-
Stephanie Salter: Another wronged woman becomes the nation’s paper doll
A few hours after the death of Elizabeth Edwards last week, the creepy, contemporary American ritual of vicarious grieving began in cyberspace.
“You are with your son now. Rest in peace.” -
Stephanie Salter: You’ve heard from me — now, listen to the teachers
As e-mail from Indiana teachers and principals continues to pour into my box, the portrait of this beleaguered group grows more poignant each day.
-
STEPHANIE SALTER: Have you heard Indiana’s schools are failing? It’s a lie
In Gov. Mitch Daniels’ recent state budget PowerPoint, he put up a comparison chart: The percentage of Indiana public school students who’ve attained an advanced level of math achievement versus “the world.” Hoosiers lag behind the national average, trailing such states as Massachusetts, Oregon and New York, and such nations as Poland and Latvia.
-
Stephanie Salter: Bashing teachers in the name of education reform
As I read the Tribune-Star’s recent Page 1 news packages about the governor’s push for education reform, I kept seeing faces.
-
Stephanie Salter: After the turkey and before the pie, a round of giving thanks
As my colleague Alicia Morgan wrote last week, there is no downside to taking time out now and then to list and truly appreciate our blessings.
-
STEPHANIE SALTER: A story of just one corporate lobby ‘investing in advocacy’
For those of you who know in your marrow that the president’s attempt to overhaul the U.S. health care system proves his socialist agenda, take the day off. What reporter Drew Armstrong of Bloomberg News shared this past week will be of no interest to you.
-
Stephanie Salter: Inside today’s grab bag …: Stamps, bands and GOP $$$
It’s time for another roundup of items, little ideas that can’t grow big enough for a whole column, but just won’t go away from my field of focus.
-
Stephanie Salter: Can’t make a decision? Consult strangers on the ’Net
A day after I heard screenwriter and director Nora Ephron talking on NPR about that moment in the aging process when you realize you are no longer cut out to be au courant, that moment arrived for me.
-
Stephanie Salter: The years may pass, but a friend will always ride shotgun
I should have known there would be a first-aid kit. Susan provided for every contingency.
How like her to have tucked a 106-piece, American Medical Association-approved kit under the passenger seat of her Honda Accord. How like me not to have discovered it until I was deep cleaning the car to get it ready to sell. - More Stephanie Salter Headlines
-
STEPHANIE SALTER: The more things change, the more they … change




